✦ LIBER ✦

Pharmacologic Study of Pegylated Liposomal Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy

✍ Scribed by Lawrence E. Harrison

Book ID: 111772491
Publisher: Springer
Year: 2008
Tongue: English
Weight: 125 KB
Volume: 15
Category: Article
ISSN: 1068-9265
DOI: 10.1245/s10434-008-0097-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I Trial of Pegylated Liposomal Dox

Phase I Trial of Pegylated Liposomal Doxorubicin with Hyperthermic Intraperitoneal Chemotherapy in Patients Undergoing Cytoreduction for Advanced Intra-abdominal Malignancy

✍ Lawrence E. Harrison; Margarette Bryan; Lilian Pliner; Tracie Saunders 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 227 KB

A phase I and pharmacologic study of the

A phase I and pharmacologic study of the combination of bortezomib and pegylated liposomal doxorubicin in patients with refractory solid tumors

✍ E. Claire Dees; Bert H. O’Neil; Celeste M. Lindley; Frances Collichio; Lisa A. C 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 527 KB

Phase I study of pegylated liposomal dox

Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar

✍ Fracasso, P M; Blum, K A; Ma, M K; Tan, B R; Wright, L P; Goodner, S A; Fears, C 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 124 KB

Chemotherapy-induced dyspareunia: a case

Chemotherapy-induced dyspareunia: a case study of vaginal mucositis and pegylated liposomal doxorubicin injection in advanced stage ovarian carcinoma

✍ Michael L Krychman; Jeanne Carter; Carol A Aghajanian; Don S Dizon; Mercedes Cas 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 75 KB

A phase II study of combination chemothe

A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin

✍ Mansoor Raza Mirza; Bente Lund; Jacob Christian Lindegaard; Nina Keldsen; Anders 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 387 KB

Long-term remission of recalcitrant tumo

Long-term remission of recalcitrant tumour-stage mycosis fungoides following chemotherapy with pegylated liposomal doxorubicin

✍ C Tsatalas; G Martinis; D Margaritis; E Spanoudakis; I Kotsianidis; A Karpouzis; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

## ABSTRACT Advanced stage mycosis fungoides (MF) generally has a poor prognosis, and currently there is no standard treatment available. Here we report the case of a young woman with recalcitrant tumour‐stage MF (T3, stage IIb) whose disease was unresponsive to several therapeutic modalities, but